Loading organizations...
§ Venture Capital · Copenhagen, Hovedstaden, Denmark
Innovative therapies for lysosomal storage diseases.
Orphazyme has raised $60.8M across 4 funding rounds.
Key people at Orphazyme.
Orphazyme has raised $60.8M in total across 4 funding rounds.
Orphazyme has raised $60.8M across 4 funding rounds. Most recently, it raised $14.9M Series B Extension in March 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 10, 2017 | $14.9M Series B Plus | — | Aescap Venture, ALS Investment Fund, Idinvest Partners, Kurma Partners, LSP, Novo Holdings, Sunstone Capital | Announced |
| Feb 11, 2015 | $22.6M Series B | Rémi Droller | Aescap Venture, Idinvest Partners, Novo Holdings, Sunstone Capital | Announced |
| Sep 9, 2011 | $19.1M Series A | — | Hakan Goker, Peter Moldt, Sunstone Capital | Announced |
| Mar 27, 2011 | $4.2M Seed | Sten Verland | Novo Holdings | Announced |
Key people at Orphazyme.
Orphazyme has raised $60.8M in total across 4 funding rounds.
Orphazyme's investors include Aescap Venture, ALS Investment Fund, Idinvest Partners, Kurma Partners, LSP, Novo Holdings, Sunstone Capital, Rémi Droller, Hakan Goker, Peter Moldt, Sten Verland.